FDA Accelerates Mental Illness Treatments Following Trump Executive Order

President Trump issued an Executive Order on April 18 directing HHS to accelerate access to treatments for serious mental illness, including treatment-resistant conditions. The FDA is taking action to expedite approval and access to these therapeutics.